Abstract:The lysophospholipids (LPLs) belong to a group of bioactive lipids that play pivotal roles in several physiological and pathological processes. LPLs are derivatives of phospholipids and consist of a single hydrophobic fatty acid chain, a hydrophilic head, and a phosphate group with or without a large molecule attached. Among the LPLs, lysophosphatidic acid (LPA) and sphingosine-1-phosphate (S1P) are the simplest, and have been shown to be involved in lung inflammatory symptoms and diseases such as acute lung i… Show more
“…Here, we showed that platelets from severe allergic patients contain altered levels of proinflammatory lipids such as sphingolipids (ceramides (Cer) and sphingomyelins (SM)), arachidonic acid (AA), and lysophospholipids (LPC). These lipids have been reported to be involved in the allergic inflammatory response 29‐31 . In this work, we have detected an increase in Cer and SM in platelets of severe allergic patients.…”
Section: Discussionsupporting
confidence: 55%
“…These lipids have been reported to be involved in the allergic inflammatory response. [29][30][31] In this work, we have detected an increase in Cer and SM in platelets of severe allergic patients. Cer and SM belong to the family of sphingolipids, and their importance in allergic diseases has been widely studied.…”
Background: Mechanisms causing the onset and perpetuation of inflammation in severe allergic patients remain unknown. Our previous studies suggested that severe allergic inflammation is linked to platelet dysfunction.
Methods:Platelet-rich plasma (PRP) and platelet-poor plasma (PPP) samples were obtained by platelet-apheresis from severe (n = 7) and mild (n = 10) allergic patients and nonallergic subjects (n = 9) to perform platelet lipidomics by liquid chromatography coupled to mass spectrometry (LC-MS) and RNA-seq analysis. Significant metabolites and transcripts were used to identify compromised biological pathways in the severe phenotype. Platelet and inflammation-related proteins were quantified by Luminex.Results: Platelets from severe allergic patients were characterized by high levels of ceramides, phosphoinositols, phosphocholines, and sphingomyelins. In contrast, they showed a decrease in eicosanoid precursor levels. Biological pathway analysis performed with the significant lipids revealed the alteration of phospholipases, calcium-dependent events, and linolenic metabolism. RNAseq confirmed mRNA overexpression of genes related to platelet activation and arachidonic acid metabolism in the severe phenotypes. Pathway analysis indicated the alteration of NOD, MAPK, TLR, TNF, and IL-17 pathways in the severe phenotype. P-Selectin and IL-17AF proteins were increased in the severe phenotype.
“…Here, we showed that platelets from severe allergic patients contain altered levels of proinflammatory lipids such as sphingolipids (ceramides (Cer) and sphingomyelins (SM)), arachidonic acid (AA), and lysophospholipids (LPC). These lipids have been reported to be involved in the allergic inflammatory response 29‐31 . In this work, we have detected an increase in Cer and SM in platelets of severe allergic patients.…”
Section: Discussionsupporting
confidence: 55%
“…These lipids have been reported to be involved in the allergic inflammatory response. [29][30][31] In this work, we have detected an increase in Cer and SM in platelets of severe allergic patients. Cer and SM belong to the family of sphingolipids, and their importance in allergic diseases has been widely studied.…”
Background: Mechanisms causing the onset and perpetuation of inflammation in severe allergic patients remain unknown. Our previous studies suggested that severe allergic inflammation is linked to platelet dysfunction.
Methods:Platelet-rich plasma (PRP) and platelet-poor plasma (PPP) samples were obtained by platelet-apheresis from severe (n = 7) and mild (n = 10) allergic patients and nonallergic subjects (n = 9) to perform platelet lipidomics by liquid chromatography coupled to mass spectrometry (LC-MS) and RNA-seq analysis. Significant metabolites and transcripts were used to identify compromised biological pathways in the severe phenotype. Platelet and inflammation-related proteins were quantified by Luminex.Results: Platelets from severe allergic patients were characterized by high levels of ceramides, phosphoinositols, phosphocholines, and sphingomyelins. In contrast, they showed a decrease in eicosanoid precursor levels. Biological pathway analysis performed with the significant lipids revealed the alteration of phospholipases, calcium-dependent events, and linolenic metabolism. RNAseq confirmed mRNA overexpression of genes related to platelet activation and arachidonic acid metabolism in the severe phenotypes. Pathway analysis indicated the alteration of NOD, MAPK, TLR, TNF, and IL-17 pathways in the severe phenotype. P-Selectin and IL-17AF proteins were increased in the severe phenotype.
“…However, as the process relied on cheap starting materials and delivered sufficient amounts of the desired ureas, no systematic optimization work was carried out. 13 C NMR spectra of ureas incorporating a 2,6diisopropylaniline usually showed two signals for the two apparently symmetric isopropyl groups, indicating reduced rotational freedom of this moiety. The carbamates 43 and 45 needed for this study were obtained in moderate to good yields by reacting the appropriate phenyl isocyanate with the corresponding phenol (Scheme 2) in the presence of an excess of ethyl-diisopropylamine as a base.…”
Section: ■ Chemistrymentioning
confidence: 99%
“…ATX , and LPAR1 , are ubiquitously expressed, and based on LPA’s implication in many pivotal cellular processes, the ATX-LPA receptor axis was proposed as a viable target to treat cardiovascular, inflammatory, ,− and proliferative diseases. ,− Remarkably, LPAR1-deficient mice showed attenuated vascular leakage and fibrosis in a bleomycin-induced lung fibrosis model . Furthermore, elevated levels of LPA were found in bronchoalveolar lavage fluid (BALF) and exhaled breath condensate from patients with idiopathic pulmonary fibrosis (IPF), , suggesting continuous activation of LPAR1 by its ligand LPA as a key mechanism contributing to fibrosis progression.…”
Lysophosphatidic acid receptor 1 (LPAR1) antagonists show promise as potentially novel antifibrotic treatments. In a human LPAR1 β-arrestin recruitment-based high-throughput screening campaign, we identified urea 19 as a hit with a LPAR1 IC 50 value of 5.0 μM. Hit-to-lead activities revealed that one of the urea nitrogen atoms can be replaced by carbon and establish the corresponding phenylacetic amide as a lead structure for further optimization. Medicinal chemistry efforts led to the discovery of piperidine 18 as a potent and selective LPAR1 antagonist with oral activity in a mouse model of LPA-induced skin vascular leakage. The molecular scaffold of 18 shares no obvious structural similarity with any other LPAR1 antagonist disclosed so far.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.